Osteosarcoma and General physical health deterioration

Summary:

General physical health deterioration is found among people with Osteosarcoma, especially for people who are female, 10-19 old.

The study analyzes which people have General physical health deterioration with Osteosarcoma. It is created by eHealthMe based on reports of 15 people who have Osteosarcoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteosarcoma?

Osteosarcoma (a cancerous (malignant) bone tumour) is found to be associated with 41 drugs and 110 conditions by eHealthMe. Check the latest studies of Osteosarcoma.

What is General physical health deterioration?

General physical health deterioration (weak health status) is found to be associated with 2,265 drugs and 2,922 conditions by eHealthMe. Check the latest studies of General physical health deterioration.



On Jul, 31, 2026

15 people who have Osteosarcoma and General Physical Health Deterioration are studied.

Would you have General physical health deterioration when you have Osteosarcoma?

Gender of people who have Osteosarcoma and experienced General Physical Health Deterioration *:

  • female: 76.92 %
  • male: 23.08 %

Age of people who have Osteosarcoma and experienced General Physical Health Deterioration *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 57.14 %
  • 20-29: 7.14 %
  • 30-39: 14.29 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 7.14 %

Common co-existing conditions for these people *:

  1. Lower Respiratory Tract Infection: 5 people, 33.33%
  2. Tumor Pain: 1 person, 6.67%
  3. Tumor: 1 person, 6.67%
  4. Nausea (feeling of having an urge to vomit): 1 person, 6.67%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 6.67%
  6. Constipation: 1 person, 6.67%

Common drugs taken by these people *:

  1. Methotrexate: 4 people, 26.67%
  2. Cisplatin: 2 people, 13.33%
  3. Cabometyx: 2 people, 13.33%
  4. Zoledronic Acid: 1 person, 6.67%
  5. Rapamune: 1 person, 6.67%
  6. Movicol: 1 person, 6.67%
  7. Doxorubicin Hydrochloride: 1 person, 6.67%
  8. Clarithromycin: 1 person, 6.67%

Common symptoms for these people *:

  1. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 33.33%
  2. Blood Creatine Increased: 5 people, 33.33%
  3. Diarrhea: 4 people, 26.67%
  4. Anal Haemorrhage: 3 people, 20.00%
  5. Renal Impairment (severely reduced kidney function): 3 people, 20.00%
  6. Multi-Organ Disorder (multiple organ disease): 3 people, 20.00%
  7. Mucosal Inflammation (infection of mucous membrane): 3 people, 20.00%
  8. Melaena (the passage of black, tarry stools): 3 people, 20.00%
  9. Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 20.00%
  10. Hepatic Function Abnormal: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have General physical health deterioration?

- Check whether General physical health deterioration is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with General physical health deterioration:

All the conditions that are associated with General physical health deterioration:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on General physical health deterioration and Osteosarcoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: